ETS-1 directly activates cyclin D1 transcription by binding to its promoter, resulting in increased Cyclin D1 protein levels, which accelerate the progression through the G1/S checkpoint and increase breast cancer cell proliferation. Here, ETS1 is linked to breast cancer.